chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diagnosis for encounter: gastritis. HPI: "Patient is a 60 year old female with PMH DM who presents to the ED complaining of hearing a "buzzing" sound for the past 3 days. She went to an outside ER yesterday for this, as well as a headache, tongue numbness, an altered sensation in the left arm, and dizziness. She had a full workup that revealed a "mass" on her lung and "something about my thyroid". She was told to follow up at hospital for further testing."
Day after vaccine woke up with mild temp of 99 but otherwise OK.  By 2:00pm had temp of 101.6 and very tired.  Temp continued but fluctuated with Tylenol for  48 hours.  Fatigue continued 2/22/21, then felt normal.
24 hrs after injection - 3 cm.  36 hrs after injection - 4 cm.  Redness - DTP.
pt recvd vax 9JAN95 330PM & mom noticed limping but no edema on the way home; t99.1 that noc but non since; only sx sleepy; 10JAN95 noted edema from hip to knee; lt thigh edema from hip to knee & is tender to touch exp @ knee pain & tender
General muscle soreness at injection site a couple hours after Excruciating bilateral shoulder joint pain with radiating nerve pain both arms at 21:00 Loss of sleep due to pain General fatigue, body aches, chills at 22:00 Majority of symptoms resolved within 24-hours
I woke up with my eyes swollen and a massive headache. The problems progressed throughout the day, my stomach started to hurt and my whole body ached. Eventually my throat started hurting. I have been sick since the 21st and today is now the 26th, I now have a 101 (f) fever but it has been jumping around from 102 (f) (at the highest) to 98.5 (lowest).
Itching. Benadryl 25 mg given. BP 127/97 (pulse 101), 99% O2 sat. BP 127/92 (pulse 87), O2 sat 97%.
She received the 1st COVID vaccine Pfizer Lot #FL8095 exp 05/31/21 at 1440. Around 2:55 PM EMT Noticed the client's mother fanning the client. EMT responded and noticed perspiration above the client's lip and pallor of the client's face.  RN'S responded. The following was obtained with RN translating between Spanish and English. The client reported feeling a headache, hot, and sweaty to RN. Vitals obtained at 2:58PM were as follows: BP 100/60, HR 78, O2 100%. RN noted the client's chest moving, appearing as if the client was catching her breath. The client stated she was crying earlier and denied any trouble breathing. The client's mom stated she last ate breakfast at 10:00 AM. RN provided the client with crackers and a juice. The client began eating the crackers. The client ambulated unassisted with a steady gait to the anti-gravity chair and sat down in a high folwer's position. The client denied any dizziness or nausea while walking. The client continued eating the crackers and drinking the juice. RN noted a decrease in pallor on the client's face. Provided education to the client and her mother regarding possible adverse reactions and when to seek medical care. RN left the scene and Interpreter  responded. The following was obtained with Interpreter translating between Spanish and English. Repeat vitals obtained at 3:12PM were as follows: BP 96/60, HR 72, O2 100%. The client stated that she felt fine and denied any current headache or arm pain. Repeat vitals obtained at 3:22 PM were as follows: BP 96/62, HR 69, O2 100%. The client stated her symptoms had resolved. The client left the vaccination site at 3:23 PM ambulating unassisted with a steady gait.
Rash/Hives on extremities. Painful bumps on hands and feet. Extreme chapped lips. Lasted 9 days.
patient had vasovagal reaction and felt light headed. She got on the ground herself and put her feet up, prevented fainting. She recovered within minutes and was given apple juice. This has happened before with other needles and procedures. She fully recovered after about 10 minutes.
PATIENT WAS VACCINATED AT 3.5 MONTHS INSTEAD OF THE 6 MONTHS LIMIT. PATIENT REPORTED NO SIDE EFFECTS WHILE WAITING AFTER THE SHOT FOR 15 MINUTES AND WAS CALLED TODAY AND REPORTED NO ADVERSE EVENTS. SHE IS NOT IMMUNOCOMPROMISED.
Painful for a week and a half at injection site; Inflammation of about 5 inches around / at injection site; Red / at injection site; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, injection site inflammation and injection site erythema. On an unknown date, the outcome of the injection site pain, injection site inflammation and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site inflammation and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had painful, inflammation of about 5 inches around, red, painful for a week and a half at injection site.
As reported by patient: tension headache and neck pain before leaving the clinic, advised to take Tylenol and drink water at home, several hours later, patient noticed her R arm was "contracted" in elbow flexion and tremors in R arm began. Patient took Tylenol daily for 1 week without resolution of symptoms. One week later, patient went to emergency department, where she was screened for stroke due to history of stroke resulting in R hemiparesis in 2018. Patient began noticing numbness/tingling in R arm, elevated blood pressure, and blurry vision. Patient was given tramadol for her R arm pain while being observed in the hospital. After discharge, patient went to the emergency department at Hospital (4/21) due to continued pain and tremors. Patient was prescribed flexiril and ibuprofen. On 4/23, her PCP prescribed Tramadol. Patient reports no change in R arm pain. Patient reports R arm tremor is improving, but still significantly affecting her.
patient had an ActHIB vaccine on 15Aug2023, however the vaccine had expired on 07Aug2023 with no reported adverse event; Initial information received on 15-Aug-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 4 years old female patient who had an HIB (PRP/T) vaccine [ACT-HIB] on 15aug2023, however the vaccine had expired on 07aug2023 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis A vaccine inact (Havrix); measles vaccine, mumps vaccine, rubella vaccine (MMR); pneumococcal vaccine conj 13V (CRM197) (Prevnar 13); varicella zoster vaccine live (OKA/MERCK) (Varivax); and diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3V (vero), tetanus vaccine toxoid (Kinrix) all for prophylactic vaccination (Immunisation).  On 15-Aug-2023, the patient received 0.5 mL dose of expired suspect HIB (PRP/T) vaccine, powder and solvent for solution for injection (batch number: UJ735AAB; expiry date: 07-Aug-2023) via intramuscular route in the right thigh for immunization with no reported adverse event (expired product administered) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event patient had an acthib vaccine on 15aug2023, however the vaccine had expired on 07aug2023 with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Tingling; Wheezing; Hives; the area around the injection site itchy; the area around the injection site red; he felt puffy lips, a itchiness on his tongue and a rash, which he describes as "nothing serious all mild; itchiness on his tongue and a rash, which he describes as "nothing serious all mild; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (he felt puffy lips, a itchiness on his tongue and a rash, which he describes as "nothing serious all mild), RASH PRURITIC ( itchiness on his tongue and a rash, which he describes as "nothing serious all mild), PARAESTHESIA (Tingling), WHEEZING (Wheezing) and URTICARIA (Hives) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (widespread rash), Drug allergy (wide spread rash), Hypertension, Gout and Chronic kidney disease. Concomitant products included LISINOPRIL and ALLOPURINOL for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced LIP SWELLING (he felt puffy lips, a itchiness on his tongue and a rash, which he describes as "nothing serious all mild) and RASH PRURITIC ( itchiness on his tongue and a rash, which he describes as "nothing serious all mild). On 27-Jan-2021, the patient experienced INJECTION SITE PRURITUS (the area around the injection site itchy) and INJECTION SITE ERYTHEMA (the area around the injection site red). On an unknown date, the patient experienced PARAESTHESIA (Tingling), WHEEZING (Wheezing) and URTICARIA (Hives). The patient was treated with LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) (oral) 19-Jan-2021 at a dose of 1 dosage form; CORTISONE at a dose of UNK dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 20-Jan-2021, LIP SWELLING (he felt puffy lips, a itchiness on his tongue and a rash, which he describes as "nothing serious all mild) and RASH PRURITIC ( itchiness on his tongue and a rash, which he describes as "nothing serious all mild) had resolved. At the time of the report, PARAESTHESIA (Tingling), WHEEZING (Wheezing), URTICARIA (Hives), INJECTION SITE PRURITUS (the area around the injection site itchy) and INJECTION SITE ERYTHEMA (the area around the injection site red) outcome was unknown.            Concomitant medications reported was provided as Blood pressure medications and Gout medications. Treatment medication also included antihistamines.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Correspondence email attached- Information of second dose like batch no. added
She is currently experiencing covid symptoms; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (She is currently experiencing covid symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (She is currently experiencing covid symptoms). At the time of the report, SUSPECTED COVID-19 (She is currently experiencing covid symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact
Patient experienced flushing + felt hot on her neck. Also said she felt tightness in her throat.
Sore arm.  Sore throat. fever. Night sweats. Loss of sleep. Swollen and enflamed roof of mouth.
Caller reported temperature excursion / Caller reported multiple administrations of both products / Temperature -13.3 C; This spontaneous report was received from a registered nurse and refers to a 13-month-old patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.   On 03-DEC-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # T017688, expiration date 21-MAY-2022, 0.5 milliliter for prophylaxis (anatomical location and route of administration were not reported).  Digital Data logger was involved. The vaccine was stored at the temperature that was reported as -13.3 degrees of Celsius for 4 hours and 15 minutes. There was no previous temperature excursion reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2101USA000235: US-009507513-2012USA013093: US-009507513-2012USA013532: US-009507513-2012USA013501: US-009507513-2012USA013524: US-009507513-2012USA013533: US-009507513-2012USA013539: US-009507513-2012USA013584: US-009507513-2012USA013585: US-009507513-2012USA013592: US-009507513-2012USA013594: US-009507513-2012USA013596: US-009507513-2012USA013598: US-009507513-2012USA013603: US-009507513-2012USA013601: US-009507513-2012USA013501: US-009507513-2012USA013095:
I have developed a at times sever pain at the stem of my head (back of the head, toward the right side).  It feels like a knot, that at times I cannot even move my head.  This is SPECIALLY true when I have had an hard alcoholic drink (Scotch or Sherry).  Does not happen with a beer.  The pain started immediately after the first vaccine.  NEVER before had this happened.  I have always been a Scotch drinker.  I did not take notice of it, and even though I reported it to the pharmacy before getting the second shot, they looked at me as if I was joking.  I stopped drinking hard drinks for a month, and had no pain.  I had another Scotch last Friday, small bottle of Sake Saturday, and Sherry Sunday afternoon.  Sent me to bed in pain, had a Motrin, to no avail.  Only today did I realize that the pain was once again coming after a drink, which takes me back to the date of the vaccine.
4 patients were given first dose in parts; first they were given 0.05ml by mistake and then remaining 0.45 ml given to them. 2 patients came within 8 hours and 2 came within 24 hours to take the remaining dose; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (4 patients were given first dose in parts; first they were given 0.05ml by mistake and then remaining 0.45 ml given to them. 2 patients came within 8 hours and 2 came within 24 hours to take the remaining dose) in a 38-year-old patient of an unknown gender who received mRNA-1273 (batch no. 041B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (4 patients were given first dose in parts; first they were given 0.05ml by mistake and then remaining 0.45 ml given to them. 2 patients came within 8 hours and 2 came within 24 hours to take the remaining dose). On 29-Apr-2021, INCORRECT DOSE ADMINISTERED (4 patients were given first dose in parts; first they were given 0.05ml by mistake and then remaining 0.45 ml given to them. 2 patients came within 8 hours and 2 came within 24 hours to take the remaining dose) had resolved.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Patient received her vaccine and had no symptoms in 30 min. post vaccination on 1/29/21. By that afternoon, she had generalized hives, malaise, and started wheezing.  She developed additional symptoms of lip swelling, edema, lightheaded, dyspnea.  She had medical contacts with telemedicine, 2 office visits here with her PCP and a couple phone follow ups with her PCP.  She was treated with benadryl, a 10 day prednisone course and a ventolin inhaler.   Her symptoms resolved after a week.
No additional AE reported; HCP reporting VAQTA, PEDVAXHIB, and ROTATEQ were administered after a temperature excursion. Caller stated she did not have the exact dates of administration nor the names of the patients involved. No additional information provided. No additional AE; This spontaneous report was received from a Health Care Professional and refers to a 4-month-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 14-DEC-2022, the patient was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) intramuscular injection, in left thigh, lot #W006596, expiration date: 11-OCT-2024, administered intramuscularly for prophylaxis (strength was not provided), and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ)  lot #1892784, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength was not provided).   The administered dose of the vaccine experienced a temperature excursion (product storage error) since 01-DEC-2022. The vaccine administered were stored at temperatures excursion of 47.9 Fahrenheit (storage in clinical practice) for 47 minutes. Data logger was involved. No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA001175: US-009507513-2301USA009088: US-009507513-2301USA009024: US-009507513-2301USA009110: US-009507513-2301USA009896:
T105 x 2 days w/febrile sz x 2;one Sunday PM 2min, one Monday in MD office 2-3min observed;no other illness noted x/mild cold sx;alert post sx, sucking thumb, some crying spells;pt sent to hosp for observation;febrile sz secondary to  vax
Shortly after second dose, patient experienced myalgias, fatigue, but 3 days later, developed chest pain with troponin elevations and was found on MRI to have myopericarditis. He is otherwise stable, He is being treated with antiinflammatories with good response
Patient stated about 6-7 hours after immunization she started having burning/itching and soreness in her muscle and it continued. I spoke with her today, 10-7-19, and she stated it is subsiding and starting to feel better.
On night of 30th of March, she felt some soreness to chest area and took Tylenol to help sleep. In morning she noticed a dime size spot that was red and painful and had a peak to it with a pus discharge.  She said the pain subsided around midday on 31stof March but it is still red and visible.  It is located between neck and breast area in middle of chest.  Only one spot. She said she is not sure when the spot came about but only noticed it on the night of 30th of March.
Not taken her 2nd dose yet,vaccine beyond the 42 days at this point; Symptoms of COVID-19,Tested positive for COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Symptoms of COVID-19,Tested positive for COVID-19) and PRODUCT DOSE OMISSION ISSUE (Not taken her 2nd dose yet,vaccine beyond the 42 days at this point) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 07-Apr-2021, the patient experienced COVID-19 (Symptoms of COVID-19,Tested positive for COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not taken her 2nd dose yet,vaccine beyond the 42 days at this point). At the time of the report, COVID-19 (Symptoms of COVID-19,Tested positive for COVID-19) and PRODUCT DOSE OMISSION ISSUE (Not taken her 2nd dose yet,vaccine beyond the 42 days at this point) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Information has been received from a registered nurse concerning a female age not specified who on approx 10/26/05, the past 48 hrs was vaccinated with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649981/0704P). On approx 10/26/05, the past 48 hrs, the pt developed significant injection site reaction, fever, chills, swelling and redness from elbow to deltoid at injection site. It was also reported that symptoms started within 12 to 24 hours of receiving the vaccine. The pt sought unspecified medical attention. There were no lab diag studies performed. The pt had been taking acetaminophen Tylenol every four hours for the events. At the time of this report, the pt had not recovered from the events. Additional information has been requested.
Information has been received from the pregnancy registry via a physician concerning an 18 year old female who on 22-AUG-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 658822/0927U). Concomitant therapy included DEPO-PROVERA. The physician stated that the patient was diagnosed with a urinary tract infection on 22-AUG-2007. The patient had a urinalysis (results not reported). On 24-AUG-2007 the patient spoke with the physician by phone to report she was two weeks pregnant. The patient last menstrual period was 10-AUG-2007 and estimated of delivery was 15-MAY-2008. Additional information is not expected.
About 9 pm, 11 hours after booster, high fever of 101 which lasted all night., upset stomach. About 14 hours after booster, severe nausea, dry heaving, some throwing up, light headed, didn't want to move because of nausea.  Lasted several hours. No sleep. Next morning, nausea almost gone, very tired.  Fever abated by mid morning. Fatigue the two days after booster.  I had no symptoms with first three shots except for sore arm.
losing feeling in fingers and they are turning white.  This has happend at least 4x now and it lasts for about 20 minutes.
Had red streak on right arm where vaccines were administered. Was given Benadryl to alleviate AE.
Inability to breath, extreme shortness of breath.Has never experienced this before. Rash on upper torso. Patient crawled to front door and opened door to cold (frigid temperatures) air, which helped him to breath. Also patient self medicated self with Sudafed and Benadryl.  Still has coldlike congestion in chest.
Fatigue,headache,fever,chills,inflamed area around injection site,sweats
LINGERING ISSUES; This spontaneous report received from a consumer concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced lingering issues. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lingering issues. This report was non-serious.